Clinical Trial Update: Safety, Tolerability, and PK/PD of Telpegfilgrastim in Premenopausal Non-pregnant Females [Phase 1]

View source ↗

Summary

This Phase 1 study assessed safety, tolerability, and PK/PD of Telpegfilgrastim in premenopausal non-pregnant women, and the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preeclampsia

Drugs mentioned

• Telpegfilgrastim (telpegfilgrastim)

Snippet

Sponsor: Xiamen Amoytop Biotech Co., Ltd. | Conditions: Preeclampsia | Phase 1 | Status: COMPLETED